Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Rifamycin Sodium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 869Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/10/2024 EUROAPI
    France
    		 EUROAPI ITALY S.R.L. Brindisi IT R1-CEP 2011-233 - Rev 03 Rifamycin sodium 2021-12-17 Valid Chemical 432
    28/10/2024 Sanofi
    France
    		 Aventis Bulk SpA - Subsidiary of Aventis Pharma Brindisi IT R0-CEP 2000-336 - Rev 03 Rifamycin sodium 2005-02-18 Withdrawn by Holder TSE 2006-10-12 432